Indore, September 7, 2025 – Indore-based lifestyle startup BIGME has officially launched its science-backed transdermal patches designed to help consumers manage sleep, stress, focus, exercise performance, period pain, and hangover relief. Founded in 2024 by entrepreneurs Arjit Jain and Gurman Bhatia, the company is positioning these “superpower patches” as a next-generation alternative to traditional pills, gummies, and supplements.
BIGME Patches
India’s wellness market has witnessed rapid transformation in recent years. While lifestyle diseases such as stress, fatigue, and insomnia are on the rise, there has also been a growing demand for quick, science-based health solutions.
The founders of BIGME, inspired by their academic and professional experiences in the United Kingdom, identified the potential of transdermal technology. Unlike capsules and powders that rely on digestion, transdermal patches deliver active ingredients directly into the bloodstream through the skin, promising faster and more consistent results.
“Our exposure in the UK helped us see how Western consumers were adopting innovative wellness formats. That’s when we realized India was ready for something similar,” said co-founder Arjit Jain.
BIGME’s Launch & Key Features
BIGME entered the Indian market in May 2025 with an initial bootstrapped investment of ₹50 lakh. Within the first 10 weeks of operations, the brand claims to have served over 2,000 customers across India.
More Read
Transdermal patches deliver 40%–70% higher absorption rates than pills or gummies, as they bypass the gut and liver to provide steady release directly into the bloodstream.
BIGME currently offers six targeted patches:
Each patch combines natural, nutraceutical, and Ayurvedic ingredients such as Ashwagandha, Holy Basil, L-Theanine, Cosmoperine, and Milk Thistle Extract. The products are marketed as free from additives and artificial regulators.
More Read
Market Impact & Startup Ecosystem
India’s nutraceuticals and wellness market is projected to cross $18 billion by 2027, with urban millennials and Gen Z leading adoption of functional health solutions.
BIGME’s entry signals a shift toward on-demand wellness formats catering to high-performance lifestyles. By offering patches that act within hours, the startup is challenging the dominance of conventional supplements.
Industry analysts suggest that the product may attract both direct-to-consumer (D2C) traction and potential institutional partnerships with gyms, corporates, and wellness centers.
Expert Insights on Transdermal Innovation
Health experts highlight that while transdermal technology is widely used in pain management and nicotine therapy, its application in lifestyle wellness is relatively new in India.
“Transdermal patches offer consistent absorption and convenience, but consumer education will be key to scaling adoption in India. Early movers like BIGME could benefit if they establish trust quickly,” noted a Delhi-based nutraceutical consultant.
Investor interest is also emerging. Recently, Bollywood actor Rohit Roy invested ₹1.5 crore for a 5% stake in BIGME and joined as a strategic growth advisor.
Future Outlook for BIGME
BIGME plans to scale its operations pan-India with delivery timelines of 5–7 days, while also expanding its product line. The founders are exploring collaborations with research labs to integrate AI-driven personalization into patch-based therapies.
The company is also eyeing global markets, given that transdermal supplements are already popular in the United States and Europe. With consumer awareness rising and the Indian wellness market evolving, BIGME’s patches may represent an early foothold in a niche but fast-growing category.
Disclaimer
The opinions expressed in this article are those of the author alone and do not necessarily reflect the views of Entrepreneur Villa, its creators or staff. Entrepreneur Villa is not responsible for the accuracy or reliability of any information presented in this content.
Frequently Asked Questions:
Answer: BIGME is an Indore-based lifestyle startup founded in 2024 by Arjit Jain and Gurman Bhatia. It offers science-backed transdermal wellness patches designed to improve sleep, reduce stress, boost focus, enhance workouts, relieve period pain, and provide hangover recovery.
Answer: Unlike pills or gummies that need digestion, BIGME’s transdermal patches deliver nutrients directly into the bloodstream through the skin, ensuring 40%–70% higher absorption rates and steady release for faster, longer-lasting effects.
Answer: BIGME currently offers six targeted patches:
Anti-anxiety patch (stress relief)
Hangover patch (post-alcohol recovery)
Lion’s Focus patch (concentration boost)
Period relief patch (menstrual comfort)
Sleep Good patch (improved sleep cycles)
Workout patch (energy & stamina support)
Answer: BIGME patches combine natural, nutraceutical, and Ayurvedic ingredients such as Ashwagandha, Holy Basil, L-Theanine, Cosmoperine, and Milk Thistle Extract. They are marketed as free from additives and artificial chemicals.
Answer: Transdermal patches bypass the gut and liver, providing higher bioavailability, consistent absorption, and fewer digestive side effects compared to traditional supplements like pills, powders, or gummies.
Answer: BIGME was founded by Arjit Jain and Gurman Bhatia, two entrepreneurs inspired by their academic and professional experiences in the UK. Their vision is to make on-demand wellness accessible to Indian consumers through innovative formats.
Answer: BIGME launched in May 2025 with a ₹50 lakh bootstrapped investment. Within just 10 weeks, the startup served over 2,000 customers across India, highlighting strong early adoption of transdermal wellness solutions.
Answer: Yes. Bollywood actor Rohit Roy recently invested ₹1.5 crore in BIGME for a 5% equity stake. He also joined as a strategic advisor, boosting the startup’s credibility and growth potential.
Answer: BIGME is pioneering patch-based nutraceuticals in India, catering to millennials and Gen Z seeking quick, science-driven wellness solutions. This innovation is reshaping the $18B nutraceuticals market projected by 2027.
Answer: BIGME plans to expand pan-India with 5–7 day delivery, launch new patch variants, and integrate AI-driven personalization in therapies. The company is also exploring global expansion, tapping into US and European demand for transdermal wellness.
